David G Carville

Title: David G. Carville: Innovator in Fibrin-Specific Antibodies

Introduction

David G. Carville is a notable inventor based in Mishawaka, IN (US). He has made significant contributions to the field of immunology through his innovative methods for producing fibrin-specific antibodies. His work is particularly relevant in medical research and therapeutic applications.

Latest Patents

David G. Carville holds a patent for a method of producing fibrin-specific antibodies using soluble fibrin. The patent describes a composition that includes soluble crosslinked DesAABB fibrin polymers and soluble non-crosslinked DesAABB fibrin polymers as immunogens. This invention is crucial as it allows for the production of antibodies that specifically bind to these fibrin polymers while avoiding binding to various fibrinogen-related substances.

Career Highlights

Carville's career is marked by his role at American Biogenic Sciences, Inc., where he has been able to apply his expertise in developing innovative solutions in the field of biomedicine. His work has the potential to advance therapeutic strategies for conditions related to fibrin and its derivatives.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Paul E. Gargan and Nada Dimitrijevic. These partnerships have likely contributed to the success and impact of his research and inventions.

Conclusion

David G. Carville's contributions to the field of immunology through his patented methods for producing fibrin-specific antibodies highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of targeted therapies in healthcare.